0.0002
0.0000
(0.00%)
As of January 29 at 3:00:00 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DIAMANDIS PETER Director | Conversion of Exercise of derivative security | Apr 26, 2023 | 919,965 |
| PRIME MOVERS LAB FUND I LP Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 8, 2023 | -- |
Related Tickers
BO1.MU BioCryst Pharmaceuticals Inc
7.53
-1.75%
ISI.SG Ionis Pharmaceuticals Inc
31.90
+1.11%
CMVLF Cellectis S.A.
1.2500
0.00%
LTI.SG Aptose Biosciences Inc
0.1600
+2.56%
PMRA.F Pharma Mar, S.A.
84.70
-1.63%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
SLGL Sol-Gel Technologies Ltd.
0.7883
+2.38%
NBYB.SG Northwest Biotherapeutics, Inc.
0.2960
+19.35%
BXRXQ Baudax Bio, Inc.
0.0000
-99.00%
OTLC Oncotelic Therapeutics, Inc.
0.0300
+7.14%